Assessing the economic impact of digital endpoints on medication adherence

Ahmad Z. Al Meslamani,Nannan Li
DOI: https://doi.org/10.1080/14737167.2024.2334893
2024-03-27
Expert Review of Pharmacoeconomics & Outcomes Research
Abstract:KEYWORDS: Adherence to medication is crucial for patient care and indispensable for reaching clinical outcomes and treatment efficacy. Poor adherence to medications affects approximately 50% of the patient population [ Citation 1 ]. This is particularly true in chronic conditions such as diabetes, asthma, chronic obstructive pulmonary disease (COPD), and hypertension with long-term therapies, leading to exacerbated health condition, increased risk of disease progression, premature deaths, prolonged use of healthcare services and significant healthcare expenditure. One systematic review [ Citation 2 ] indicated that the annual adjusted disease-specific economic cost of non-adherence per person ranged from 44,190 (in 2015 US$). Appropriate interventions are therefore necessary to improve medication adherence and reduce the economic burden.
pharmacology & pharmacy,health care sciences & services,health policy & services
What problem does this paper attempt to address?